Zepp Health Corporation reported unaudited financial results for the third quarter of 2025, with revenue reaching $75.8 million, a 78.5% year-over-year increase. The company recorded a GAAP operating loss of $0.9 million and adjusted operating income of $0.4 million, compared to losses of $12.5 million and $11.3 million, respectively, in the same period of 2024. Net loss attributable to Zepp Health was $1.6 million, down from $13.3 million last year, while adjusted net loss was $0.7 million, compared to $11.8 million in the third quarter of 2024. Adjusted expenses as a percentage of sales improved to 37.7% from 67.3% in the prior year. Zepp Health reduced its total loan balance by $64.5 million since early 2023 and plans to continue its share repurchase program in 2026. For the fourth quarter of 2025, the company expects revenue between $82.0 million and $86.0 million, representing a projected year-over-year increase of 38% to 45%.